Our Mission

Founded in 2020, The GSD3 Foundation is the world’s only non-profit 501(c)(3) organization completely dedicated to advancing the treatment of glycogen storage disease type III. All funds raised by The GSD3 Foundation directly support health and science professionals’ research on improved treatment options and a cure for this rare disease.

Meet the Founders

Founders Evan and Katie Ouellette

(Pictured with children Avery, Quinn and Maren (far right), who was diagnosed with GSD 3a at 10 months old)

Our Scientific Advisory Board

Composed of worldwide experts in the field, our Scientific Advisory Board includes:

  • Terry Derks, M.D., Ph.D., Associate Professor, University of Groningen, The Netherlands

  • Areeg El-Gharbawy, M.D., D.Sc., Associate Professor, Clinician and Researcher, Duke University Medical Center, Durham, N.C.

  • Ulrike Steuerwald, M.D., M.P.H., Pediatrician, National Hospital of the Faroe Islands, Medical Center, Tórshavn, Faroe Islands

  • David Weinstein, M.D., M.M.Sc., Weinstein Rare Disease and Clinical Developmental Consulting, Philadelphia, P.A.

One in a Million

Glycogen Storage Disease is an extremely rare condition and type 3 is particularly uncommon. In the United States, it affects only one in a million individuals.

While this video is from 2018 (yes, it’s old!), it still provides a helpful overview of GSD and Maren’s journey, which led to the development of The GSD3 Foundation.